PAHSymposium Evaluation

I activin symposium

We would be most grateful if you could kindly take a few minutes to answer these questions. Your valuable feedback will help us improve the quality of our symposium, and we look forward to hearing your thoughts.

The topics discussed in this symposium are relevant to my clinical practice *

Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Strongly agreeItem #1 Strongly agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly disagreeItem #1 Strongly disagree

The symposium enhanced my understanding of using a first-in-class activin signalling inhibitor to achieve better outcomes for pulmonary arterial hypertension *

Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Strongly agreeItem #1 Strongly agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly disagreeItem #1 Strongly disagree

Overall, I am satisfied with this symposium *

Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Strongly agreeItem #1 Strongly agree	AgreeItem #1 Agree	NeutralItem #1 Neutral	DisagreeItem #1 Disagree	Strongly disagreeItem #1 Strongly disagree

Merck Sharp & Dohme (Asia) Ltd.
27/F Lee Garden Two, 28 Yun Ping Road, Causeway Way, Hong Kong
Tel: (852) 3971 2800 Fax: (852) 2834 0756
Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved.
HK-SOT-00023 JAN/2025